We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Nivolumab and ipilimumab
Australian Public Assessment Report
Device/Product Name
Opdivo and Yervoy/Winglore
Active ingredients
Nivolumab and ipilimumab
AusPAR Date
Published
Submission Number
PM-2018-02005-1-4 and PM-2018-02012-1-4
Submission Type
Extension of indication
Decision
Withdrawn